CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30TH SEPTEMBER 2022
Statement of Financial Position
Group | Company | |||||||||
As at, | Unaudited | Audited | Unaudited | Audited | ||||||
30th Sep 2022 | 31st Dec 2021 | 30th Sep 2022 | 31st Dec 2021 | |||||||
Note | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | ||||||
Assets | 367,752 | 210,986 | ||||||||
Property, Plant and Equipment | 282,884 | 141,390 | ||||||||
Right of Use Assets | 406,372 | 395,148 | 371,507 | 362,336 | ||||||
Intangible Assets | 59,794 | 63,180 | 55,409 | 57,839 | ||||||
Deferred Tax Assets | 47,896 | 291,832 | - | 273,543 | ||||||
Financial Investments | 3 | 32,516,155 | 29,094,085 | 27,700,528 | 24,667,102 | |||||
Investment in Subsidiary | - | - | 1,150,000 | 1,150,000 | ||||||
Loans to Life Policyholders | 410,121 | 403,452 | 410,121 | 403,452 | ||||||
Reinsurance Receivables | 1,236,605 | 1,072,206 | 219,202 | 317,009 | ||||||
Premium Receivables | 1,355,738 | 1,247,997 | 58,993 | 7,822 | ||||||
Other Assets | 1,000,067 | 747,946 | 702,556 | 507,528 | ||||||
Insurance Contract - Deferred Expenses | 165,460 | 157,710 | - | - | ||||||
Cash and Cash Equivalents | 1,533,310 | 2,112,745 | 1,064,111 | 1,575,931 | ||||||
Total Assets | 39,099,270 | 35,869,185 | 31,943,413 | 29,463,952 | ||||||
Equity and Liabilities | ||||||||||
Equity Attributable to the Equity Holders | 1,171,875 | 1,171,875 | ||||||||
Stated Capital | 1,171,875 | 1,171,875 | ||||||||
Retained Earnings | 7,517,588 | 6,644,680 | 6,280,121 | 5,548,813 | ||||||
Available for Sale Reserve | (366,201) | 4,009 | (135,849) | 4,446 | ||||||
Other Reserve | (11,421) | (11,421) | (6,614) | (6,614) | ||||||
Life Policyholders' Available for Sale Reserve Fund | 5 | (1,268,433) | (67,291) | (1,268,433) | (67,291) | |||||
Restricted Regulatory Reserve | 6 | 381,156 | 381,156 | 381,156 | 381,156 | |||||
Equity Attributable to the Equity Holders | 7,424,564 | 8,123,008 | 6,422,256 | 7,032,385 | ||||||
Non-Controlling Interest | - | - | - | - | ||||||
Total Equity | 7,424,564 | 8,123,008 | 6,422,256 | 7,032,385 | ||||||
Liabilities | 23,297,701 | 23,297,701 | ||||||||
Insurance Contract Liabilities - Life Insurance | 7 | 20,342,757 | 20,342,757 | |||||||
Insurance Contract Liabilities - General Insurance | 8 | 4,175,561 | 3,735,922 | - | - | |||||
Employee Defined Benefit Liabilities | 277,777 | 239,167 | 160,468 | 137,328 | ||||||
Current Tax Liabilities | 129,227 | 62,168 | 84,002 | 19,871 | ||||||
Reinsurance Creditors | 819,106 | 1,085,512 | 260,038 | 453,054 | ||||||
Lease Creditors | 437,849 | 421,838 | 402,880 | 390,374 | ||||||
Other Liabilities | 2,245,715 | 1,747,148 | 1,181,738 | 1,034,819 | ||||||
Bank Overdrafts | 291,770 | 111,665 | 134,330 | 53,364 | ||||||
Total Liabilities | 31,674,706 | 27,746,177 | 25,521,157 | 22,431,567 | ||||||
Total Equity and Liabilities | 39,099,270 | 35,869,185 | 31,943,413 | 29,463,952 | ||||||
The Notes form an integral part of these Condensed Consolidated Interim Financial Statements.
These Condensed Consolidated Interim Financial Statements are in compliance with the requirements of the Companies Act, No. 07 of 2007.
Punsirini Perera
Chief Financial Officer
The Board of Directors is responsible for these Condensed Consolidated Interim Financial Statements.
Signed on behalf of the Board;
Rose Cooray | Ashoka Goonesekere |
Chairperson | Director |
Colombo, Sri Lanka | |
10th November 2022 |
1
Statement of Profit or Loss and Other Comprehensive Income
Group | ||||||||||||||
(Audited) | Group | Company | Change | |||||||||||
Year Ended | Unaudited | Unaudited | Unaudited | Unaudited | Group Company | |||||||||
31st Dec 2021 | For the Nine Months Ended 30th September, | 2022 | 2021 | 2022 | 2021 | |||||||||
Rs. '000 | Note | Rs. '000 | Rs. '000 | Rs. '000 | Rs. '000 | % | % | |||||||
12,646,947 | Gross Written Premium | 9 | 11,311,277 | 8,960,358 | 6,597,219 | 4,993,503 | 26 | 32 | ||||||
(1,648,861) | Premium Ceded to Reinsurers | (1,491,672) | (1,173,900) | (348,607) | (256,631) | 27 | 36 | |||||||
10,998,086 | Net Written Premium | 9,819,605 | 7,786,458 | 6,248,612 | 4,736,872 | 26 | 32 | |||||||
(242,252) | Net Change in Reserves for Unearned Premium | (149,012) | (62,292) | - | - | 139 | - | |||||||
10,755,834 | Net Earned Premium | 9,670,593 | 7,724,166 | 6,248,612 | 4,736,872 | 25 | 32 | |||||||
Other Revenue | ||||||||||||||
2,555,274 | Interest and Dividend Income | 10 | 2,999,070 | 1,881,096 | 2,643,176 | 1,729,883 | 59 | 53 | ||||||
52,921 | Net Realised Gains | 361,017 | 19,717 | 95,486 | 16,905 | 1,731 | 465 | |||||||
79,128 | Net Fair Value (Losses)/Gains | (10,233) | 77,277 | (30,575) | 50,584 | (113) | (160) | |||||||
225,738 | Fee and Commission Income | 212,930 | 162,376 | 43,085 | 68,849 | 31 | (37) | |||||||
13,334 | Other Income | 17,204 | 12,225 | 15,625 | 2,213 | 41 | 606 | |||||||
2,926,395 | Total Other Revenue | 3,579,988 | 2,152,691 | 2,766,797 | 1,868,434 | 66 | 48 | |||||||
13,682,229 | Net Income | 13,250,581 | 9,876,857 | 9,015,409 | 6,605,306 | 34 | 36 | |||||||
Net Benefits, Claims and Expenses | ||||||||||||||
(4,223,290) | Net Insurance Benefits and Claims | (4,031,521) | (2,935,903) | (1,583,120) | (1,188,563) | 37 | 33 | |||||||
(3,249,356) | Change in Contract Liabilities - Life Fund | (3,023,350) | (3,056,156) | (3,023,350) | (3,056,156) | (1) | (1) | |||||||
(2,892,824) | Other Operating and Administration Expenses | (2,854,716) | (2,060,767) | (1,731,959) | (1,172,278) | 39 | 48 | |||||||
(1,456,258) | Underwriting and Net Acquisition Costs | (1,297,843) | (1,006,342) | (1,007,042) | (734,789) | 29 | 37 | |||||||
(112,123) | Finance and Other Insurance Related Costs | (93,157) | (86,283) | (78,981) | (61,549) | 8 | 28 | |||||||
(11,933,851) | Total Benefits, Claims and Other Expenses | (11,300,587) | (9,145,451) | (7,424,452) | (6,213,335) | 24 | 19 | |||||||
1,748,378 | Profit Before Taxation | 1,949,994 | 731,406 | 1,590,957 | 391,971 | 167 | 306 | |||||||
(524,730) | Income Tax Expense | 11 | (424,597) | (266,309) | (379,649) | (184,120) | 59 | 106 | ||||||
1,223,648 | Profit for the Period | 12 | 1,525,397 | 465,097 | 1,211,308 | 207,851 | 228 | 483 |
Other Comprehensive Income, Net of Related Tax
Items that are or may be reclassified to profit or loss
(914,208) - Net Change in fair value of Available For Sale Financial Assets
(9,490) - Realised Gains transferred to Income Statement
- - Amortisation of AFS reserve on reclassification
- Net Change in fair value of Available For Sale Financial Assets
825,224 - transferred to Life Policyholders' Available For Sale Reserve Fund
8,729 | - Related Tax | 11 |
Items that will never be reclassified to profit or loss | ||
44,140 | - Actuarial Gains on Defined Benefit Plans | |
(4,041) | - Related Tax | 11 |
(49,646) | Total Other Comprehensive Income for the Period, Net of Related Tax | |
1,174,002 | Total Comprehensive Income for the Period | |
Profit Attributable to: | ||
1,223,648 Equity Holders of the Company
- Non-ControllingInterest
Total Comprehensive Income Attributable to:
1,174,002 Equity Holders of the Company
- Non-ControllingInterest
8.16 | Basic and Diluted Earnings Per Share (Rs.) | 13 |
(1,618,386) | (673,721) | (1,362,925) | (607,692) | 140 | 124 |
- | (5,874) | - | (5,874) | 100 | 100 |
21,488 | - | 21,488 | - | 100 | 100 |
1,201,142 | 604,562 | 1,201,142 | 604,562 | 99 | 99 |
25,546 | 13,626 | - | - | 87 | - |
- | - | - | - | - | - |
- | - | - | - | - | - |
(370,210) | (61,407) | (140,295) | (9,004) | 503 | 1,458 |
1,155,187 | 403,690 | 1,071,013 | 198,847 | 186 | 439 |
1,525,397 | 465,097 | 1,211,308 | 207,851 | 228 | 483 |
- | - | - | - | - | - |
1,155,187 | 403,690 | 1,071,013 | 198,847 | 186 | 439 |
- | - | - | - | - | - |
10.17 | 3.10 | 8.08 | 1.39 | 228 | 483 |
The Notes form an integral part of these Condensed Consolidated Interim Financial Statements.
2
3
Statement of Changes in Equity - Group
For the Period Ended 30th September, | Stated | Retained | Available | Other | Life | Restricted | Total | |
Capital | Earnings | for Sale | Reserve | Policyholders' | Regulatory | Equity | ||
Reserve | AFS Reserve | Reserve | ||||||
Rs. '000 | Rs. '000 | Rs. '000 | Fund | Rs. '000 | ||||
Rs. '000 | Rs. '000 | Rs. '000 | ||||||
Balance as at 01st January 2021 | 1,171,875 | 5,841,032 | 93,754 | (51,520) | 757,933 | 381,156 | 8,194,230 | |
Comprehensive Income for the Period | ||||||||
Profit for the Period-Unaudited | - | 465,097 | - | - | - | - | 465,097 | |
Other Comprehensive Income for the Period, Net of Related Tax | ||||||||
Net Change in fair value of Available For Sale Financial Assets | - | - | (665,969) | - | - | - | (665,969) | |
Net Change in fair value of Available For Sale Financial Assets | ||||||||
- transferred to Life Policyholders' Available For Sale Reserve Fund | - | - | 604,562 | - | - | - | 604,562 | |
Total Other Comprehensive Income for the Period | - | - | (61,407) | - | - | - | (61,407) | |
Total Comprehensive Income for the Period | - | 465,097 | (61,407) | - | - | - | 403,690 | |
Net Change in fair value of Available For Sale Financial Assets | ||||||||
- transferred from Available For Sale Reserve | - | - | - | - | (604,562) | - | (604,562) | |
Transactions with owners recorded directly in equity | ||||||||
Distributions to owners of the Parent | ||||||||
Final dividend to equity holders for 2020 | - | (420,000) | - | - | - | - | (420,000) | |
Unaudited balance as at 30th September 2021 | 1,171,875 | 5,886,129 | 32,347 | (51,520) | 153,371 | 381,156 | 7,573,358 | |
Comprehensive Income for the Period | ||||||||
Profit for the Period-Unaudited | - | 758,551 | - | - | - | - | 758,551 | |
Other Comprehensive Income for the Period, Net of Related Tax | ||||||||
Net Change in fair value of Available For Sale Financial Assets | - | - | (249,000) | - | - | - | (249,000) | |
Net Change in fair value of Available For Sale Financial Assets | ||||||||
- transferred to Life Policyholders' Available For Sale Reserve Fund | - | - | 220,662 | - | - | - | 220,662 | |
Actuarial Gains on Defined Benefit Plans | - | - | - | 40,099 | - | - | 40,099 | |
Total Other Comprehensive Income for the Period | - | - | (28,338) | 40,099 | - | - | 11,761 | |
Total Comprehensive Income for the Period | - | 758,551 | (28,338) | 40,099 | - | - | 770,312 | |
Net Change in fair value of Available For Sale Financial Assets | ||||||||
- transferred from Available For Sale Reserve | - | - | - | - | (220,662) | - | (220,662) | |
Audited balance as at 31st December 2021 | 1,171,875 | 6,644,680 | 4,009 | (11,421) | (67,291) | 381,156 | 8,123,008 | |
Balance as at 01st January 2022 | 1,171,875 | 6,644,680 | 4,009 | (11,421) | (67,291) | 381,156 | 8,123,008 | |
Surcharge Tax | (Note 16) | - | (172,489) | - | - | - | - | (172,489) |
Comprehensive Income for the Period | ||||||||
Profit for the Period-Unaudited | - | 1,525,397 | - | - | - | - | 1,525,397 | |
Other Comprehensive Income for the Period, Net of Related Tax | ||||||||
Net Change in fair value of Available For Sale Financial Assets | - | - | (1,571,352) | - | - | - | (1,571,352) | |
Net Change in fair value of Available For Sale Financial Assets | ||||||||
- transferred to Life Policyholders' Available For Sale Reserve Fund | - | - | 1,201,142 | - | - | - | 1,201,142 | |
Total Other Comprehensive Income for the Period | - | - | (370,210) | - | - | - | (370,210) | |
Total Comprehensive Income for the Period | - | 1,525,397 | (370,210) | - | - | - | 1,155,187 | |
Net Change in fair value of Available For Sale Financial Assets | ||||||||
- transferred from Available For Sale Reserve | - | - | - | - | (1,201,142) | - | (1,201,142) | |
Transactions with owners recorded directly in equity | ||||||||
Distributions to owners of the Parent | ||||||||
Dividend to equity holders for 2021 | - | (480,000) | - | - | - | - | (480,000) | |
Unaudited balance as at 30th September 2022 | 1,171,875 | 7,517,588 | (366,201) | (11,421) | (1,268,433) | 381,156 | 7,424,564 |
Stated Capital represents 150 Million Ordinary Shares as at 30th September 2022 (2021 - 150 Million).
The Notes form an integral part of these Condensed Consolidated Interim Financial Statements.
4
Statement of Changes in Equity - Company
For the Period Ended 30th September 2022, | Stated | Retained | Available | Other | Life | Restricted | Total |
Capital | Earnings | for Sale | Reserve | Policyholders' | Regulatory | Equity | |
Reserve | AFS Reserve | Reserve | |||||
Rs. '000 | Rs. '000 | Rs. '000 | Fund | Rs. '000 | |||
Rs. '000 | Rs. '000 | Rs. '000 | |||||
Balance as at 01st January 2021 | 1,171,875 | 4,968,314 | 15,626 | (33,916) | 757,933 | 381,156 | 7,260,988 |
Comprehensive Income for the Period | |||||||
Profit for the Period-Unaudited | - | 207,851 | - | - | - | - | 207,851 |
Other Comprehensive Income for the Period, Net of Related Tax | |||||||
Net Change in fair value of Available For Sale Financial Assets | - | - | (613,566) | - | - | - | (613,566) |
Net Change in fair value of Available For Sale Financial Assets | |||||||
- transferred to Life Policyholders' Available For Sale Reserve Fund | - | - | 604,562 | - | - | - | 604,562 |
Total Other Comprehensive Income for the Period | - | - | (9,004) | - | - | - | (9,004) |
Total Comprehensive Income for the Period | - | 207,851 | (9,004) | - | - | - | 198,847 |
Net Change in fair value of Available For Sale Financial Assets | |||||||
- transferred from Available For Sale Reserve | - | - | - | - | (604,562) | - | (604,562) |
Transactions with owners recorded directly in equity | |||||||
Distributions to owners of the Company | |||||||
Final dividend to equity holders for 2020 | - | (420,000) | - | - | - | - | (420,000) |
Unaudited balance as at 30th September 2021 | 1,171,875 | 4,756,165 | 6,622 | (33,916) | 153,371 | 381,156 | 6,435,273 |
Comprehensive Income for the Period | |||||||
Profit for the Period-Unaudited | - | 792,648 | - | - | - | - | 792,648 |
Other Comprehensive Income for the Period, Net of Related Tax | |||||||
Net Change in fair value of Available For Sale Financial Assets | - | - | (222,838) | - | - | - | (222,838) |
Net Change in fair value of Available For Sale Financial Assets | |||||||
- transferred to Life Policyholders' Available For Sale Reserve Fund | - | - | 220,662 | - | - | - | 220,662 |
Actuarial Gains on Defined Benefit Plans | - | - | - | 27,302 | - | - | 27,302 |
Total Other Comprehensive Income for the Period | - | - | (2,176) | 27,302 | - | - | 25,126 |
Total Comprehensive Income for the Period | - | 792,648 | (2,176) | 27,302 | - | - | 817,774 |
Net Change in fair value of Available For Sale Financial Assets | |||||||
- transferred from Available For Sale Reserve | - | - | - | - | (220,662) | - | (220,662) |
Audited balance as at 31st December 2021 | 1,171,875 | 5,548,813 | 4,446 | (6,614) | (67,291) | 381,156 | 7,032,385 |
Balance as at 01st January 2022 | 1,171,875 | 5,548,813 | 4,446 | (6,614) | (67,291) | 381,156 | 7,032,385 |
Comprehensive Income for the Period | |||||||
Profit for the Period-Unaudited | - | 1,211,308 | - | - | - | - | 1,211,308 |
Other Comprehensive Income for the Period, Net of Related Tax | |||||||
Net Change in fair value of Available For Sale Financial Assets | - | - | (1,341,437) | - | - | - | (1,341,437) |
Net Change in fair value of Available For Sale Financial Assets | |||||||
- transferred to Life Policyholders' Available For Sale Reserve Fund | - | - | 1,201,142 | - | - | - | 1,201,142 |
Total Other Comprehensive Income for the Period | - | - | (140,295) | - | - | - | (140,295) |
Total Comprehensive Income for the Period | - | 1,211,308 | (140,295) | - | - | - | 1,071,013 |
Net Change in fair value of Available For Sale Financial Assets | |||||||
- transferred from Available For Sale Reserve | - | - | - | - | (1,201,142) | - | (1,201,142) |
Transactions with owners recorded directly in equity | |||||||
Distributions to owners of the Company | |||||||
Dividend to equity holders for 2021 | - | (480,000) | - | - | - | - | (480,000) |
Unaudited balance as at 30th September 2022 | 1,171,875 | 6,280,121 | (135,849) | (6,614) | (1,268,433) | 381,156 | 6,422,256 |
Stated Capital represents 150 Million Ordinary Shares as at 30th September 2022 (2021 - 150 Million).
The Notes form an integral part of these Condensed Consolidated Interim Financial Statements.
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
HNB Assurance plc published this content on 11 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 November 2022 10:11:01 UTC.